Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia
- PMID: 38571280
- DOI: 10.1111/ijd.17153
Review of the use of Janus kinase inhibitors in the treatment of scarring alopecia
Keywords: JAK inhibitor; Janus kinase inhibitor; central centrifugal cicatricial alopecia; cicatricial alopecia; dissecting cellulitis of the scalp; folliculitis decalvans; frontal fibrosing alopecia; lichen planopilaris; scarring alopecia.
References
-
- Filbrandt R, Rufaut N, Jones L, Sinclair R. Primary cicatricial alopecia: diagnosis and treatment. CMAJ. 2013;185(18):1579–1585. https://doi.org/10.1503/cmaj.111570
-
- Triyangkulsri K, Suchonwanit P. Role of janus kinase inhibitors in the treatment of alopecia areata. Drug Des Devel Ther. 2018;12:2323–2335. https://doi.org/10.2147/DDDT.S172638
-
- Shao S, Tsoi LC, Sarkar MK, Xing X, Xue K, Uppala R, et al. IFN‐γ enhances cell‐mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Sci Transl Med. 2019;11(511):eaav7561. https://doi.org/10.1126/scitranslmed.aav7561
-
- Del Duca E, Ruano Ruiz J, Pavel AB, Sanyal RD, Song T, Gay‐Mimbrera J, et al. Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing. Br J Dermatol. 2020;183(6):1083–1093. https://doi.org/10.1111/bjd.19040
-
- National Library of Medicine. Dual JAK1/TYK2 inhibitor for cicatricial. 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
